April 16, 2015 | The Trendlines Group portfolio company Leviticus Cardio announced that it raised over $1.5 million from private investors. The company will reportedly use the funds to commence its “first-in-man” feasibility study with the unique Coplanar Energy System. Leviticus Cardio is a medical device company founded in 2008 dedicated to improve the clinical outcome for patients implanted with a left ventricular assist device (LVAD) for impaired cardiac function.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments